FDA clears non-invasive TTTS ultrasound device by Q2 2027
Resolves: An FDA 510(k) clearance announcement is published for a non-invasive TTTS ultrasound device, with the device explicitly cited for treating twin-to-twin transfusion syndrome.
user-generated· regulatory
FDA clears non-invasive TTTS ultrasound device by Q2 2027
Market overview
The FDA will grant 510(k) clearance to at least one medical device manufacturer for a non-invasive TTTS ultrasound system by the end of Q2 2027. This follows the submission of clinical data from the UK trial and additional preclinical studies.
regulatory prediction market
- Implied probability (Yes)
- 70%
- Closes
- 2027-06-30
About this prediction
Resolution criteria
An FDA 510(k) clearance announcement is published for a non-invasive TTTS ultrasound device, with the device explicitly cited for treating twin-to-twin transfusion syndrome.
Source: user-generated
More regulatory markets
- Major cloud providers will ban AI access to ransomware-related APIs by Q1 2027 — 80% Yes
- CISA adopts mandatory incident playbook by December 2026 — 85% Yes
- US water utilities increase cybersecurity spending by 30% — 72% Yes
- Hartlepool council approves new lifeguard training program by 2027 — 70% Yes
- Polling firms adjust methodology after Midwest misses — 60% Yes
- Democrats pass AI regulatory bill by Q2 2027 — 65% Yes
- SEC approves new guidelines for crypto custody within 6 months — 60% Yes
- EU and UK expand joint anti-smuggling task force within 9 months — 70% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…